T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
CALL
Wells Fargo
WFC
$269B
| $22.1M | ﹤0.01% |
364,000
| – | – |
|
1152
Howard Hughes
HHH
$3.98B
| $22.1M | ﹤0.01% |
176,309
-1,852
| -1% | -$221K |
|
1153
International Flavors & Fragrances
IFF
$21.4B
| $22.1M | ﹤0.01% |
144,564
-1,419
| -1% | -$213K |
|
1154
ACI Worldwide
ACIW
$5.33B
| $22M | ﹤0.01% |
971,056
+65,531
| +7% | +$1.52M |
|
|
SLCA
1155
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $22M | ﹤0.01% |
675,437
-18,760
| -3% | -$598K |
|
|
POLY
1156
DELISTED
Plantronics, Inc.
POLY
| $22M | ﹤0.01% |
436,325
-23,706
| -5% | -$1.17M |
|
1157
Enanta Pharmaceuticals
ENTA
$393M
| $21.8M | ﹤0.01% |
372,010
+269,566
| +263% | +$13.5M |
|
1158
CenterPoint Energy
CNP
$26.7B
| $21.8M | ﹤0.01% |
768,262
+5,100
| +0.7% | +$149K |
|
1159
Jazz Pharmaceuticals
JAZZ
$16B
| $21.7M | ﹤0.01% |
161,511
+2,094
| +1% | +$290K |
|
1160
Golub Capital BDC
GBDC
$3.48B
| $21.7M | ﹤0.01% |
1,216,767
-27,056
| -2% | -$501K |
|
1161
Healthpeak Properties
DOC
$14.2B
| $21.6M | ﹤0.01% |
829,723
-18,300
| -2% | -$485K |
|
1162
Pultegroup
PHM
$24.6B
| $21.5M | ﹤0.01% |
647,870
-105,760
| -14% | -$3.28M |
|
1163
Floor & Decor
FND
$6.32B
| $21.5M | ﹤0.01% |
441,995
+2,540
| +0.6% | +$103K |
|
|
CTXS
1164
DELISTED
Citrix Systems Inc
CTXS
| $21.5M | ﹤0.01% |
244,200
-5,200
| -2% | -$440K |
|
1165
PUT
JPMorgan Chase
JPM
$965B
| $21.4M | ﹤0.01% |
200,000
| – | – |
|
|
ARD
1166
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $21.3M | ﹤0.01% |
1,010,717
+195
| +0% | +$4.01K |
|
|
CBIO
1167
Crescent Biopharma
CBIO
$610M
| $21.2M | ﹤0.01% |
12,650
+1,661
| +15% | +$2.2M |
|
1168
Unum
UNM
$14.5B
| $21.2M | ﹤0.01% |
386,625
| – | – |
|
1169
Hilltop Holdings
HTH
$2.25B
| $21.1M | ﹤0.01% |
834,904
+29,954
| +4% | +$735K |
|
|
ECHO
1170
EchoStar
ECHO
$26.6B
| $21.1M | ﹤0.01% |
435,250
+18,565
| +4% | +$862K |
|
1171
Mid-America Apartment Communities
MAA
$15.4B
| $21.1M | ﹤0.01% |
210,012
+2,690
| +1% | +$279K |
|
1172
W.W. Grainger
GWW
$61.5B
| $21.1M | ﹤0.01% |
89,373
-6,200
| -6% | -$1.28M |
|
1173
Seagate
STX
$209B
| $21M | ﹤0.01% |
502,855
-5,300
| -1% | -$202K |
|
1174
Integer Holdings
ITGR
$4.25B
| $21M | ﹤0.01% |
464,155
+44,790
| +11% | +$2.18M |
|
1175
LKQ Corp
LKQ
$6.25B
| $21M | ﹤0.01% |
516,045
-235,033
| -31% | -$9M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.